Benjamin F. Edwards & Company, Inc. Novavax Inc Transaction History

Benjamin F. Edwards & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $21,289 - $47,840	-268 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$13.86 - $83.61 $15,246 - $91,971	-1,100 Reduced 80.41%	268 $22,000
Q1 2020 May 07, 2020	BUY	$3.93 - $16.0 $3,144 - $12,800	800 Added 140.85%	1,368 $19,000
Q2 2019 Aug 08, 2019	BUY	$4.93 - $12.2 $2,800 - $6,929	568 New	568 $3,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.